0001179110-18-012333.txt : 20181024 0001179110-18-012333.hdr.sgml : 20181024 20181024155708 ACCESSION NUMBER: 0001179110-18-012333 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20181016 FILED AS OF DATE: 20181024 DATE AS OF CHANGE: 20181024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Durkin Brian L CENTRAL INDEX KEY: 0001756865 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 181136403 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 3 1 edgar.xml FORM 3 - X0206 3 2018-10-16 0 0001551152 AbbVie Inc. ABBV 0001756865 Durkin Brian L 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 0 1 0 0 VP, Controller Common stock, $0.01 par value 4251 D Common stock, $0.01 par value 253 I By spouse Option (right to buy) 64.12 2026-07-24 Common stock 5240 D Option (right to buy) 61.36 2027-02-15 Common stock 7180 D Option (right to buy) 114.36 2019-02-15 2028-02-14 Common stock 3110 D The reporting person disclaims beneficial ownership of all securities held by his spouse. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 1,747 shares on 7/25/2017 and as to 1,746 shares on 7/25/2018, and becomes exercisable as to 1,747 shares on 7/25/2019. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 2,394 shares on 2/16/2018, and becomes exercisable as to 2,393 shares on 2/16/2019 and as to 2,393 shares on 2/16/2020. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 1,037 shares on 02/15/2019, 1,036 shares on 02/15/2020, and 1,037 shares on 02/15/2021. Steven Scrogham, attorney-in-fact for Brian L. Durkin 2018-10-24 EX-24 2 briandurkinpoa.txt POWER OF ATTORNEY The undersigned constitutes and appoints LAURA J. SCHUMACHER, KATHLEEN M.S. SCHEIDT, JENNIFER M. LAGUNAS and STEVEN L. SCROGHAM, and each of them individually, as the undersigned's true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for the undersigned and in the undersigned's name, place and stead, to prepare and sign any and all Securities and Exchange Commission ("SEC") Notices of Proposed Sales of Securities pursuant to Rule 144 under the Securities Act of 1933 on Form 144, all SEC statements on Forms 3, 4 and 5 as required under Section 16(a) of the Securities Exchange Act of 1934, including a Form ID and any other documents necessary to obtain codes and passwords necessary to make electronic filings, and any amendments or successors to such forms, and to file the same with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite, necessary or desirable to be done under said Rule 144 and Section 16(a), as fully for all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent may lawfully do or cause to be done by virtue hereof. A copy of this power of attorney shall be filed with the SEC. The authorization set forth above shall continue in full force and effect until the undersigned is no longer required to file Forms 144, 3, 4, or 5 or if earlier, until the undersigned revokes such authorization by written instructions to the attorney-in-fact. Date: October 17, 2018 /s/ Brian L. Durkin Signature of Reporting Person Brian L. Durkin Name AbbVie Inc. 1 N. Waukegan Road North Chicago, IL 60064